FGFR1 and neoplasm: However, the fact that translocations and mutations of the FGFR1 gene lead to a constitutively activated FGFR1 protein in around 10% of tumours [179–181] highlights the unique role of FGFR1 as an oncogene and its accountability during the arise of resistance.